PS.

NHS National Generic Pharmaceuticals Transition 2021_1

The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02aba832014L0024active

Estimated value

—

goods

Awarded value

—

Suppliers

39

17 SME

Lots

4

39 awarded

Published

29 Apr 2021

Description

Transition and 33 % products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months).The total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months).

Scope

Reference
CM/PHG/20/5629
Commercial tool
Standalone contract
Main category
goods
CPV classifications
33600000
33690000
Contract locations
UK

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
——price—

Submission & procedure

Procedure
Open procedure

Award details· 39 awards

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

—

Contract end

—

Awarded to
AL
Ascend Laboratories UK Ltd
SME
AP
Aspire Pharma Limited
SME
BA
Brown and Burk UK Ltd
SME
DL
Day Lewis Medical Ltd
MP
Martindale Pharma
PU
Panpharma UK Limited
SME
AP
Aventis Pharma ltd t/a Sanofi
MP
medac Pharma LLP
AP
Aspen Pharma Ireland Limited
KP
Kent Pharma Ltd
SME
AP
Aspire Pharma Limited
SME
DL
Day Lewis Medical Ltd
MP
Morningside Pharmaeuticals
SME
PL
Pfizer Ltd
TU
Teva UK Limited
TL
Tillomed Laboratories ltd
TA
Thornton and Ross Ltd
AL
Accord-UK Ltd
MP
medac Pharma LLP
AL
Amarox Limited
SME
DL
Dr.Reddy's Laboratories (UK) Limited
SME
AP
Aspen Pharma Ireland Limited
MP
Morningside Pharmaeuticals
SME
TU
Teva UK Limited
KP
Kent Pharma Ltd
SME
PU
Panpharma UK Limited
SME
PL
Pfizer Ltd
SS
Selective Supplies Ltd.
SME
AL
Accord-UK Ltd
AP
Aspen Pharma Ireland Limited
MP
medac Pharma LLP
DL
Dr.Reddy's Laboratories (UK) Limited
SME
KP
Kent Pharma Ltd
SME
DL
Day Lewis Medical Ltd
MP
Morningside Pharmaeuticals
SME
PU
Panpharma UK Limited
SME
PL
Pfizer Ltd
RU
Ranbaxy UK
TU
Teva UK Limited

Lots · 4 total

Divisions of the contract. Each lot can be awarded separately.

View all →
LotTitleEst. valueStatus
01Transition 2021_1 - 100% Products (All regions)—cancelled
02Transition 2021_1 - CESW region (Transition & 33% products)—cancelled
03Transition 2021_1 - LSNE region (Transition & 33% products)—cancelled
04Transition 2021_1 - NWLN region (Transition & 33% products)—cancelled